Gta: glyceryltriacetate    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
307Canavan disease1

307. Canavan disease    [ 3 clinical trials,   5 drugs,   (DrugBank: 1 drug),   0 drug target gene,   0 drug target pathway]
Searched query = "Canavan disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 3 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00278707
(ClinicalTrials.gov)
January 200615/1/2006GTA-Glyceryltriacetate for Canavan DiseasePhase 1 Treatment With GTA in Two Infant With Canavan DiseaseInfantile Canavan Disease;Deficiency Disease, AspartoacylaseDrug: GTA: GlyceryltriacetateSheba Medical CenterNULLActive, not recruitingN/A15 MonthsBoth5Phase 1Israel